(NASDAQ: GLPG) Galapagos Nv's forecast annual revenue growth rate of -7.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 99.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.
Galapagos Nv's revenue in 2025 is $334,866,279.On average, 13 Wall Street analysts forecast GLPG's revenue for 2025 to be $18,820,862,448, with the lowest GLPG revenue forecast at $17,242,627,598, and the highest GLPG revenue forecast at $21,228,082,452. On average, 13 Wall Street analysts forecast GLPG's revenue for 2026 to be $18,575,725,344, with the lowest GLPG revenue forecast at $17,113,469,339, and the highest GLPG revenue forecast at $20,302,228,604.
In 2027, GLPG is forecast to generate $17,547,072,066 in revenue, with the lowest revenue forecast at $13,328,341,580 and the highest revenue forecast at $19,166,163,100.